NRC
GILD icon

New Republic Capital’s Gilead Sciences GILD Stock Holding History

New Republic Capital’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$423K Buy
3,346
+631
+23% +$83.1K 0.1% 162
2026
Q1 		$378K Sell
2,715
-1,251
-32% -$175K 0.13% 149
2025
Q4 		$487K Buy
3,966
+1,993
+101% +$242K 0.13% 141
2025
Q3 		$219K Buy
1,973
+47
+2% +$5.34K 0.07% 176
2025
Q2 		$214K Buy
+1,926
New +$205K 0.08% 168

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

New Republic Capital's GILD Position: Q2 2026 in Review

New Republic Capital increased its Gilead Sciences (GILD) stake by 23% in Q2 2026, buying an estimated $83.1K and bringing the position to 3,346 shares worth $423K. The position accounts for 0.1% of the portfolio, ranked #162.

New Republic Capital first reported a position in GILD in Q2 2025 and has held it in 5 quarters since. The position peaked at $487K in Q4 2025. 2,291 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • New Republic Capital held 3,346 shares of Gilead Sciences worth $423K as of Q2 2026.
  • New Republic Capital bought 631 Gilead Sciences shares in Q2 2026, an estimated $83.1K.
  • Gilead Sciences made up 0.1% of New Republic Capital's portfolio in Q2 2026, its #162 holding.
  • New Republic Capital first reported a position in Gilead Sciences in Q2 2025 and has held it in 5 quarters since.
  • New Republic Capital's Gilead Sciences position peaked at $487K in Q4 2025.
  • 2,291 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on New Republic Capital's 13F filing for Q2 2026, filed 31 Jul 2026.